Short Summary
Berkshire Hathaway Energy and its constituents have moved to terminate the IPR concerning the ’517 emissions patent after WEC Energy Group settled with BirchTech. The motion cites statutory requirements and public policy favoring settlement before any merits decision.
Detailed Summary
In IPR2025-00280, Berkshire Hathaway Energy Company and its affiliates filed a joint motion to terminate the inter partes review as to WEC Energy Group, Inc., following a settlement between WEC and patent owner BirchTech Corp. The parties argue that no decision on the merits has been rendered, satisfying 35 U.S.C. §317(a), and that public policy supports settlement to conserve resources. The motion also seeks to dismiss WEC from the proceeding and reconstitute the remaining petitioners, while requesting that the settlement agreement be kept confidential under 35 U.S.C. §317(b). Related litigation includes an MDL in the Southern District of Iowa and a pending case in the District of Delaware.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Berkshire Hathaway Energy Company et al. vs MES, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Ford Motor CompanyvsAutoConnect Holdings LLC
Ford Motor Company filed a response urging the PTAB Director to deny AutoConnect’s request for review of a discretionary denial, emphasizing settled expectations from its long‑term Flextronics relationship and AutoConnect’s lapses in fee payments and commercialization. The filing argues that these factors preclude any expectation that the ’153 patent would be enforced against Ford.
Thermaltake Technology Co., Ltd. et al.vsChen, Chien-Hao et al.
Thermaltake has filed an IPR petition seeking cancellation of all five claims of Lian Li’s illumination‑fan patent, arguing they are obvious over multiple prior‑art references. The petition also argues that the Board should not deny institution under discretionary statutes.
Imperative Care, Inc.vsInari Medical, Inc. et al.
The PTAB instituted inter partes review on all fifteen claims of Inari Medical’s ’005 patent, finding Imperative Care’s obviousness arguments against the hemostasis valve features sufficiently plausible.
UNION ELECTRIC COMPANY et al.vsMES, Inc.
BirchTech (MES, Inc.) opposes Union Electric’s request for Director Review of a denied institution of an IPR covering a mercury‑control patent. The response argues the Director’s decision is final, the patent’s litigation history does not merit reversal, and procedural requests for joinder and stay are untimely.
Taiwan Semiconductor Manufacturing Company Ltd.vsAdvanced Integrated Circuit Process LLC
TSMC petitions the PTAB to institute an IPR against Advanced Integrated Circuit Process’s 7,632,751 patent, seeking cancellation of 20 claims covering dummy‑via dual‑damascene methods. The petition relies on multiple grounds of anticipation and obviousness under §§102 and 103.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.